An	an	O	O	O	O
extremely	extremely	O	O	O	O
rare	rare	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
delusional	delusional	O	DISEASE	OTHERS	I
parasitosis	parasitosis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
chronic	chronic	O	DISEASE	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
C	c	O	DISEASE	OTHERS	I
patient	patient	O	O	O	O
during	during	O	O	O	O
pegylated	pegylated	O	O	OTHERS	I
interferon	interferon	O	O	OTHERS	I
alpha-2b	alpha-2b	O	O	OTHERS	I
and	and	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
chronic	chronic	O	DISEASE	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
C	c	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
with	with	O	O	O	O
interferon	interferon	O	O	OTHERS	I
and	and	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
lot	lot	O	O	O	O
of	of	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
are	are	O	O	O	O
described	described	O	O	O	O
.	.	O	O	O	O

Twenty-three	twenty-three	O	O	O	O
percent	percent	O	O	O	O
to	to	O	O	O	O
44	44	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
develop	develop	O	O	O	O
depression	depression	O	DISEASE	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
minority	minority	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
evolve	evolve	O	O	O	O
to	to	O	O	O	O
psychosis	psychosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

To	to	O	O	O	O
the	the	O	O	O	O
best	best	O	O	O	O
of	of	O	O	O	O
our	our	O	O	O	O
knowledge	knowledge	O	O	O	O
,	,	O	O	O	O
no	no	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
psychogenic	psychogenic	O	DISEASE	OTHERS	I
parasitosis	parasitosis	O	DISEASE	OTHERS	I
occurring	occurring	O	O	O	O
during	during	O	O	O	O
interferon	interferon	O	O	OTHERS	I
therapy	therapy	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
described	described	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
present	present	O	O	O	O
a	a	O	O	O	O
49-year-old	49-year-old	O	O	O	O
woman	woman	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
a	a	O	O	O	O
delusional	delusional	O	DISEASE	OTHERS	I
parasitosis	parasitosis	O	DISEASE	OTHERS	I
during	during	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
pegylated	pegylated	O	O	OTHERS	I
interferon	interferon	O	O	OTHERS	I
alpha-2b	alpha-2b	O	O	OTHERS	I
weekly	weekly	O	O	O	O
and	and	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

She	she	O	O	O	O
complained	complained	O	O	O	O
of	of	O	O	O	O
seeing	seeing	O	O	O	O
parasites	parasites	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
larvae	larvae	O	O	O	O
of	of	O	O	O	O
fleas	fleas	O	O	O	O
in	in	O	O	O	O
her	her	O	O	O	O
stools	stools	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
could	could	O	O	O	O
not	not	O	O	O	O
be	be	O	O	O	O
confirmed	confirmed	O	O	O	O
by	by	O	O	O	O
any	any	O	O	O	O
technical	technical	O	O	O	O
examination	examination	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
the	the	O	O	O	O
complaints	complaints	O	O	O	O
disappeared	disappeared	O	O	O	O
after	after	O	O	O	O
stopping	stopping	O	O	O	O
pegylated	pegylated	O	O	OTHERS	I
interferon	interferon	O	O	OTHERS	I
alpha-2b	alpha-2b	O	O	OTHERS	I
and	and	O	O	O	O
reappeared	reappeared	O	O	O	O
after	after	O	O	O	O
restarting	restarting	O	O	O	O
it	it	O	O	O	O
.	.	O	O	O	O

She	she	O	O	O	O
had	had	O	O	O	O
a	a	O	O	O	O
complete	complete	O	O	O	O
sustained	sustained	O	O	O	O
viral	viral	O	O	O	O
response	response	O	O	O	O
.	.	O	O	O	O

